3 ms·
Still big news that anyone is even doing phase 1 trials, since you wouldn't tend to bother if you didn't intend to follow up with further phases. I.e. "X is saf
by derefr 7y ago
Still big news that anyone is even doing phase 1 trials, since you wouldn't tend to bother if you didn't intend to follow up with further phases. I.e. "X is safe in a phase 1 trial" is never a useful terminal fact that you set out to prove and then, having proven it, do nothing more.
- arkades 7y agoThe vast majority of drugs don't make it through phase 3. Most will fail by the end of phase 2. If we trumpeted every time a prospective intervention underwent the earliest phases of study... well, I guess we'd have what we have had for years. Constant claims of miracle drugs on the way, with almost no subsequent impact on human lives. If you find the endless hype a source of optimism and hope, then ... well, I guess I /am/ glad you have another source of optimism and hope. I don't share it, though.
- derefr 7y agoOh, to be clear, I'm not excited by the prospect of psilocybin making it all the way to FDA approval. What excites me is that this is more evidence of a pattern of change in what medical research is being conducted. There were many drugs that we were "leaving on the table" before, that we're actually bothering to look into now. Whether or not they turn out to work for anything, at least we'll know, instead of pretending they don't exist!